In Q3, these efforts continued to pay off as revenue growth accelerated for a third consecutive quarter. Given the strong performance and the accelerating momentum we are seeing across the business, ...

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across ...

RESEARCH TRIANGLE PARK, N.C. - The U.S. Food and Drug Administration has accepted Opus Genetics Inc.’s (NASDAQ:IRD) supplemental New Drug Application for phentolamine ophthalmic solution 0.75% to ...

Research shared at Kansas State University’s 113th Cattlemen’s Day showed cows that shed earlier can wean calves more than 40 ...

RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene ...

A sweeping new peer-reviewed study published in Genomic Psychiatry has introduced a concept that could reshape how psychiatrists and geneticists think about mental illness: genetic specificity.

A research team led by scientists at the Butantan Institute in São Paulo, Brazil, has completed the most extensive genetic sequencing of a jararaca viper to date. The focus of the study was the genome ...

Ocugen Inc OCGN shares are surging on Wednesday afternoon after Oppenheimer analyst Leland Gershell initiated coverage with an Outperform rating and a $10 price target. Here’s what investors need to ...

Amid intensifying global competition in the seed industry, China's pursuit of high-quality agricultural development has ...

The FDA approved leucovorin for cerebral folate deficiency linked to FOLR1 mutations but said evidence is insufficient to support approval for autism.